ALLIANCEBERNSTEIN L.P. - NPS PHARMACEUTICALS INC ownership

NPS PHARMACEUTICALS INC's ticker is P103PS and the CUSIP is 62936P103. A total of 184 filers reported holding NPS PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 0.98 and the average weighting 0.3%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of NPS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2014$64,801,000
+3.3%
1,811,609
-24.9%
0.05%
+1.9%
Q3 2014$62,712,000
-31.0%
2,412,013
-12.3%
0.05%
-31.2%
Q2 2014$90,937,000
+21.7%
2,751,488
+10.2%
0.08%
+18.5%
Q1 2014$74,713,000
+11.6%
2,496,246
+13.2%
0.06%
+8.3%
Q4 2013$66,922,000
+306.7%
2,204,276
+326.1%
0.06%
+275.0%
Q3 2013$16,456,000
+455.6%
517,332
+163.7%
0.02%
+433.3%
Q2 2013$2,962,000196,1580.00%
Other shareholders
NPS PHARMACEUTICALS INC shareholders Q3 2013
NameSharesValueWeighting ↓
HARVEY CAPITAL MANAGEMENT INC 549,425$16,680,0006.89%
Opaleye Management Inc. 205,000$5,945,000,0004.67%
Rhenman & Partners Asset Management AB 240,000$7,286,0002.85%
SECTORAL ASSET MANAGEMENT INC 1,774,919$53,887,0002.32%
Eventide Asset Management 242,700$7,368,0002.27%
OAK RIDGE INVESTMENTS LLC 2,713,717$82,389,0002.16%
First Light Asset Management, LLC 68,245$2,072,0001.76%
Broadfin Capital, LLC 400,000$12,144,0001.60%
Cupps Capital Management, LLC 748,175$22,714,0001.54%
FCG ADVISORS, LLC 70,651$2,145,0001.45%
View complete list of NPS PHARMACEUTICALS INC shareholders